93 results on '"Trichosporonosis diagnosis"'
Search Results
2. White Piedra: More Than Trichosporon Species Infection.
- Author
-
Huang CH and Sun PL
- Subjects
- Humans, Trichosporonosis microbiology, Trichosporonosis diagnosis, Trichosporonosis drug therapy, Male, Trichosporon isolation & purification, Trichosporon classification, Trichosporon genetics, Piedra microbiology, Piedra diagnosis, Piedra pathology
- Published
- 2024
- Full Text
- View/download PDF
3. Rhinocerebral mucormycosis and Trichosporon asahii fungemia in a pediatric patient with acute lymphoblastic leukemia: a rare coinfection.
- Author
-
Hu L, Liu G, and Chen X
- Subjects
- Humans, Male, Fatal Outcome, Infant, Opportunistic Infections microbiology, Opportunistic Infections complications, Pseudomonas Infections drug therapy, Pseudomonas Infections microbiology, Pseudomonas Infections complications, Antifungal Agents therapeutic use, Basidiomycota, Mucormycosis complications, Mucormycosis diagnosis, Precursor Cell Lymphoblastic Leukemia-Lymphoma complications, Fungemia microbiology, Fungemia drug therapy, Coinfection microbiology, Trichosporonosis microbiology, Trichosporonosis diagnosis, Trichosporonosis drug therapy
- Abstract
Mucormycosis is a rare life-threatening opportunistic infection, with rhinocerebral mucormycosis (ROCM) being the most common presentation. Trichosporon asahii is an emerging pathogen that often causes fatal infections in patients with underlying hematologic malignancies due to its high drug resistance. We report a rare case of concomitant rhinocerebral mucormycosis and T. asahii fungemia secondary to Pseudomonas aeruginosa sepsis in a patient with neutropenia and acute lymphoblastic leukemia. A boy aged one year and two months was diagnosed with B-cell acute lymphoblastic leukemia on January 10 and underwent three courses of regular chemotherapy. He experienced neutropenia for 154 days and was hospitalized for vomiting, diarrhea and fever for 3 days. The day after hospitalization, Pseudomonas aeruginosa was isolated by blood culture and ceftazidime/avibactam was administered. Extracorporeal Membrane Oxygenation (ECMO) was used to provide continuous extracorporeal respiration and circulation for the patient. On day 8, the patient developed T. asahii fungemia. On day 10, he presented with necrotizing skin caused by Rhizopus delemar. He was treated with liposomal amphotericin B for Rhizopus delemar and voriconazole for T. asahii infection. Unfortunately, his health deteriorated and he died on day 11 due to the rapid progression of the infection and multiple organ failure. The management and treatment of such a complex infection requires a multidisciplinary approach and close monitoring of the patient's condition. Therefore, it is imperative to continue to research and report rare cases such as this to further understand the complexities of mucormycosis and trichosporidiosis coinfection and improve patient outcomes.
- Published
- 2024
- Full Text
- View/download PDF
4. Erythematous ulcero-proliferative exophytic lesion in an oral squamous cell carcinoma patient- An unusual case of Trichosporonosis.
- Author
-
Kesavachandran U and Kumar CA
- Subjects
- Humans, Basidiomycota, Histocytochemistry, Microscopy, Trichosporon isolation & purification, Trichosporon pathogenicity, Carcinoma, Squamous Cell diagnosis, Mouth Neoplasms pathology, Trichosporonosis diagnosis, Trichosporonosis microbiology, Trichosporonosis pathology, Trichosporonosis drug therapy
- Abstract
Abstract: The emergence of non-Candida yeast infections in humans has been increasingly recognized over the last decades. Trichosporon is the third most isolated non-candidal yeast in patients with an impaired immune system. We report a rare case of Trichosporon asahii causing erythematous oral lesion in a patient with squamous cell carcinoma. Our case highlights the occurrence of unusual yeast pathogens in patients with cancer with typical clinical presentations and warrants suspicion of fungal etiology to prevent misdiagnosis of trichosporonosis., (Copyright © 2023 Copyright: © 2023 Indian Journal of Pathology and Microbiology.)
- Published
- 2024
- Full Text
- View/download PDF
5. Trichosporon spp.: what's new?
- Author
-
Lima YP and Dias VC
- Subjects
- Humans, Antifungal Agents pharmacology, Antifungal Agents therapeutic use, Trichosporon genetics, Trichosporonosis diagnosis, Trichosporonosis drug therapy, Trichosporonosis epidemiology
- Published
- 2024
- Full Text
- View/download PDF
6. Effect of warm and humid days on the positivity rate of anti-Trichosporon asahii antibody test for the diagnosis of summer-type hypersensitivity pneumonitis.
- Author
-
Endo S, Okamoto T, Kawahara T, Anzai T, Takahashi K, and Miyazaki Y
- Subjects
- Humans, Antibodies, Fungal analysis, Seasons, Antibodies, Trichosporonosis diagnosis, Alveolitis, Extrinsic Allergic diagnosis, Basidiomycota
- Abstract
Background: Summer-type hypersensitivity pneumonitis (SHP) has been reported to occur during warm and humid summer seasons in Japan; however, the effect of weather conditions on SHP remains unknown. Anti-Trichosporon asahii antibody (TaAb) test is highly specific and useful for the diagnosing SHP. Therefore, we aimed to investigate the impact of weather conditions on SHP by examining the relationship between the positivity rate of TaAb and warm and humid days., Methods: TaAb test data from June 2013 to June 2020 were obtained from major commercial laboratories to determine the number of samples and positivity rate of TaAb by prefecture. Using the Japan Meteorological Agency database, we counted the warm and humid days (maximum temperature ≥25 °C and average humidity ≥80 %) for each prefecture. Negative binomial regression was employed to examine the relationship between the positivity rate of TaAb and the number of warm and humid days per month., Results: A total of 79,211 samples and 7626 positive samples (9.6 %) were identified. We found that the number of warm and humid days, 1 or 2 months prior to testing for TaAb, was associated with the positivity rate of the test. An increase in the positivity rate by 1.6 % and 2.9 % was observed with every 1-day increase in warm and humid days 1 month and 2 months before the test, respectively., Conclusions: Our TaAb analysis revealed a significant increase in TaAb positivity 1 or 2 months after periods of warm and humid days., Competing Interests: Declaration of competing interest The authors have no conflict of interest., (Copyright © 2023 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
7. Skin Manifestations of Micafungin Breakthrough Disseminated Trichosporonosis in Acute Megakaryoblastic Leukemia.
- Author
-
Matsumoto Y, Arakawa S, Sadahira K, Sato T, Yamazaki K, and Nishimoto S
- Subjects
- Male, Humans, Micafungin, Antifungal Agents therapeutic use, Voriconazole, Erythema complications, Erythema drug therapy, Trichosporonosis diagnosis, Trichosporonosis drug therapy, Trichosporonosis microbiology, Leukemia, Megakaryoblastic, Acute complications, Leukemia, Megakaryoblastic, Acute drug therapy, Trichosporon, Hematologic Neoplasms complications, Hematologic Neoplasms drug therapy
- Abstract
Disseminated trichosporonosis is a rare fungal infection whose risk factors are hematological malignancies and neutropenia. Recently, breakthrough Trichosporon infections after administration of micafungin, the first-line systemic antifungal agent in compromised hosts, have been widely recognized. A man in his seventies about 1 month into chemotherapy for acute megakaryoblastic leukemia presented with a worsening fever and dyspnea. The patient was being administered with empirical micafungin therapy for suspected candidiasis. As the symptoms progressed, scattered erythema appeared on the trunk, some with a dark red vesicle at the center. Blood cultures identified Trichosporon asahii, as did the specimen of the skin biopsy. On the basis also of the presence of pneumonia on chest computed tomography, we confirmed the diagnosis of disseminated trichosporonosis and changed the antifungal agent from micafungin to voriconazole. Blood culture turned out to be negative 1 month after administrating voriconazole. However, the patient died of the leukemia. Our review of previous reports on cutaneous manifestations of disseminated trichosporonosis revealed that despite their morphological diversity, erythema with a red papule or vesicle at the center, implying necrosis, was also observed in previous cases. Our case report suggests that dermatologists should be aware of skin manifestations of disseminated trichosporonosis after micafungin administration, especially in cases of hematological malignancies.
- Published
- 2024
- Full Text
- View/download PDF
8. Nasal trichosporonosis in 2 mixed-breed ewes.
- Author
-
Fredriks D, Grissett-Hardwick G, and Baumgartner W
- Subjects
- Female, Animals, Sheep, Lung, Trichosporonosis diagnosis, Trichosporonosis microbiology, Trichosporonosis veterinary, Pneumonia veterinary, Trichosporon, Sheep Diseases diagnosis
- Abstract
Two adult mixed-breed ewes were presented with a 2-wk history of upper respiratory disease. Both animals were depressed, with bilateral serosanguineous nasal discharge and harsh bronchovesicular sounds accompanied by crackles and wheezes on auscultation. One animal was recumbent and was euthanized at presentation. The other animal with similar signs, as well as exophthalmos, was euthanized because of a mass in the nasal passages. On autopsy, severe pyogranulomatous and necrotizing ethmoidal rhinitis with focal pyogranulomatous pneumonia was diagnosed in both animals. An intralesional fungal organism was identified in the nares and lungs of both animals. The organism could not be isolated via fungal culture but was identified as Trichosporon sp. by a PCR assay. Trichosporon spp. are rarely associated with disease in veterinary medicine. This ubiquitous fungus might cause disease following trauma to the nasal passages or secondary to immunocompromise.
- Published
- 2023
- Full Text
- View/download PDF
9. Identification of Clinical Trichosporon asteroides Strains by MALDI-TOF Mass Spectrometry: Evaluation of the Bruker Daltonics Commercial System and an In-House Developed Library.
- Author
-
Francisco EC, Ebbing M, Colombo AL, and Hagen F
- Subjects
- Humans, Databases, Factual, Species Specificity, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization methods, Trichosporon classification, Trichosporon isolation & purification, Trichosporonosis diagnosis, Trichosporonosis microbiology, Mycological Typing Techniques methods
- Abstract
Trichosporon asteroides is an emerging yeast-like pathogen commonly misidentified by commercial biochemical identification systems. We evaluated the performance of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for the identification of 21 clinical T. asteroides strains using the Bruker Daltonics database (BDAL) and an in-house developed library. Mass spectra were obtained by the FlexControl system v.3.4, and characterizations were performed in the Biotyper BDAL database v.4.1 and the developed in-house library. Species identification for T. asteroides failed as all 21 strains were misidentified as T. japonicum (log-scores 1.89-2.19). Extending the existing database was crucial to achieving 100% correct species-level identification and accurate distinction between species. Our results indicate that the commercial BDAL database has no discriminatory power to distinguish between T. japonicum and T. asteroides. Whereas improvement of the current BDAL database is pending, we strongly advise system users not to exclude the possibility of the failure to report T. asteroides., (© 2023. The Author(s), under exclusive licence to Springer Nature B.V.)
- Published
- 2023
- Full Text
- View/download PDF
10. Orthopedic infections due to Trichosporon species: Case series and literature review.
- Author
-
Mello López A, da Silva Neto LA, de Oliveira VF, de Carvalho VC, de Oliveira PRD, and Lima ALLM
- Subjects
- Animals, Retrospective Studies, Antifungal Agents therapeutic use, Voriconazole therapeutic use, Trichosporon, Trichosporonosis diagnosis, Trichosporonosis drug therapy, Trichosporonosis veterinary
- Abstract
Reports of orthopedic fungal infections caused by Trichosporon species are extremely scarce, thus we aimed to describe a case series and review the cases published in the literature. Patients were retrospectively included if a previous culture of bone, joint, or soft tissues had resulted positive for Trichosporon species along with a clinical diagnosis of an orthopedic infection. Eight patients were included with diverse orthopedic conditions, most of them cases of osteomyelitis. The main isolated species was Trichosporon asahii. All patients were treated with antifungals, mainly voriconazole, and surgical management, resulting in high rates of clinical improvement and low associated mortality., (© The Author(s) 2023. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.)
- Published
- 2022
- Full Text
- View/download PDF
11. JMM Profile: Trichosporon yeasts: from superficial pathogen to threat for haematological-neutropenic patients.
- Author
-
Francisco EC and Hagen F
- Subjects
- Humans, Antifungal Agents pharmacology, Antifungal Agents therapeutic use, Echinocandins, Basidiomycota, Trichosporon, Trichosporonosis diagnosis, Trichosporonosis drug therapy, Trichosporonosis microbiology
- Abstract
Trichosporon yeasts are classical agents of superficial mycoses, and they are ranked as the first to second predominant basidiomycetous yeast able to cause invasive infections. The clinical presentation of Trichosporon infections varies with the affected anatomical site, with fungaemia present in the majority of invasive trichosporonosis cases. Only a limited number of antifungal compounds can be used to treat Trichosporon infections. Azoles are the first choice due to their intrinsic resistance to echinocandins. Better laboratory methods and up-to-date databases of commercial platforms are required to improve identification, susceptibility testing and surveillance of this potentially threating infection.
- Published
- 2022
- Full Text
- View/download PDF
12. Multifocal Trichosporon asahii Infection in a Patient With Chronic Granulomatous Disease.
- Author
-
Khalil N, Kasten JL, Marsh RA, and Danziger-Isakov L
- Subjects
- Humans, Antifungal Agents therapeutic use, Granulomatous Disease, Chronic complications, Granulomatous Disease, Chronic diagnosis, Trichosporonosis diagnosis, Trichosporonosis drug therapy, Trichosporon, Basidiomycota
- Published
- 2022
- Full Text
- View/download PDF
13. Trichosporon asahii causing subcutaneous mycoses in an immunocompetent patient: case report and a minireview.
- Author
-
Kruschewsky WLL, Massaroni-Peçanha P, Maifrede SB, Leite MS, Pôssa TAL, Alberto-Lei F, Cayô R, Peçanha PM, and Gonçalves SS
- Subjects
- Antifungal Agents therapeutic use, Azoles therapeutic use, Basidiomycota, Fluconazole therapeutic use, Humans, Voriconazole therapeutic use, Dermatomycoses drug therapy, Trichosporon, Trichosporonosis diagnosis, Trichosporonosis drug therapy, Trichosporonosis microbiology
- Abstract
Trichosporon spp. are a constituent of the normal flora of humans that can cause both superficial and invasive infections, mainly in immunocompromised and immunocompetent hosts, respectively. Herein, we a report of Trichosporon asahii causing subcutaneous fungal infection (SFI) in an immunocompetent patient after carpal tunnel surgery. Although susceptible to fluconazole, the treatment of SFI failed even using high doses of this azole. The skin lesion improved following the administration of voriconazole. We conducted a literature minireview searching reports on SFI in immunocompetent patients to check for epidemiological, diagnostic, therapeutic, and outcome characteristics. A total of 32 cases were reported. Despite being uncommon, the clinical suspicion and early diagnosis of SFI in immunocompetent patients undergoing previous surgery are important. Our study indicated that the azoles are the most active antifungal agents against Trichosporon spp., except for fluconazole, and voriconazole can be considered the first therapeutic option., (© 2022. The Author(s) under exclusive licence to Sociedade Brasileira de Microbiologia.)
- Published
- 2022
- Full Text
- View/download PDF
14. EQUAL Trichosporon Score 2022: an ECMM score to measure QUALity of the clinical management of invasive Trichosporon infections.
- Author
-
Sprute R, Bethe U, Chen SC, and Cornely OA
- Subjects
- Antifungal Agents therapeutic use, Blood Culture, Humans, Basidiomycota, Trichosporon, Trichosporonosis diagnosis, Trichosporonosis drug therapy
- Abstract
Background: Invasive infections due to Trichosporon spp. are life-threatening opportunistic fungal infections that require complex clinical management. Guidelines assist clinicians but can be challenging to comply with., Objectives: To develop a scoring tool to facilitate and quantify adherence to current guideline recommendations for invasive trichosporonosis., Methods: We reviewed the current guideline for managing rare yeast infections (ECMM, ISHAM and ASM). The most important recommendations for diagnosis, treatment and follow-up were assembled and weighted according to their strength of recommendation and level of evidence. Additional items considered highly relevant for clinical management were also included., Results: The resulting EQUAL Trichosporon Score 2022 comprises 18 items, with a maximum score of 39 points. For diagnostics, seven or eight items, depending on whether organ involvement is present or not, apply, resulting in a maximum of 18 or 21 points. Recommendations on diagnostics include imaging, infectious diseases expert consultation, culture, microscopy, molecular techniques, histopathology, and susceptibility testing. For treatment, six recommendations with a maximum of ten points were identified, with two additional points for organ involvement and one point for second-line treatment in uncontrolled disease. Treatment recommendations include immediate initiation, source control, pharmacological treatment, therapeutic drug monitoring, treatment duration and surgical intervention. Follow-up comprises two items with five points maximum, covering follow-up blood cultures and imaging., Conclusions: The EQUAL Trichosporon Score weighs and aggregates factors recommended for optimal management of Trichosporon infections. It provides a tool for antifungal stewardship as well as for measuring guideline adherence, but remains to be correlated with patient outcomes., (© The Author(s) 2022. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy.)
- Published
- 2022
- Full Text
- View/download PDF
15. Possible Trichosporon asahii urinary tract infection in a critically ill COVID-19 patient.
- Author
-
Vianello M, Jesus DFF, Sampaio JM, de Oliveira GM, Lincopan N, and Ishida K
- Subjects
- Aged, Antifungal Agents therapeutic use, Basidiomycota, Critical Illness, Humans, Male, Pandemics, COVID-19, Mycoses drug therapy, Mycoses microbiology, Trichosporon, Trichosporonosis diagnosis, Trichosporonosis drug therapy, Trichosporonosis microbiology, Urinary Tract Infections drug therapy, Urinary Tract Infections microbiology
- Abstract
Background: Trichosporon asahii, an emerging fungal pathogen, has been frequently associated with invasive infections in critically ill patients., Case Report: A 74-year-old male patient diagnosed with COVID-19 was admitted to an Intensive Care Unit (ICU). During hospitalization, the patient displayed episodes of bacteremia by Staphylococcus haemolyticus and a possible urinary tract infection by T. asahii. While the bacterial infection was successfully treated using broad-spectrum antibiotics, the fungal infection in the urinary tract was unsuccessfully treated with anidulafungin and persisted until the patient died., Conclusions: With the evolving COVID-19 pandemic, invasive fungal infections have been increasingly reported, mainly after taking immunosuppressant drugs associated with long-term broad-spectrum antibiotic therapy. Although Candida and Aspergillus are still the most prevalent invasive fungi, T. asahii and other agents have emerged in critically ill patients. Therefore, a proper surveillance and diagnosing any fungal infection are paramount, particularly in COVID-19 immunocompromised populations., (Copyright © 2022 Asociación Española de Micología. Publicado por Elsevier España, S.L.U. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
16. Breakthrough Trichosporon asahii in a Patient With New Diagnosis B-ALL on Echinocandin Prophylaxis: A Case Report.
- Author
-
Mahoney D and Aftandilian C
- Subjects
- Antifungal Agents therapeutic use, Echinocandins therapeutic use, Humans, Basidiomycota, Trichosporon, Trichosporonosis diagnosis, Trichosporonosis drug therapy
- Abstract
Invasive fungal disease is a difficult to diagnose complication of therapy in patients with hematologic malignancy. Antifungal prophylaxis is recommended in high-risk populations, but its use in other populations is less clear. This brief report describes a patient with Trisomy 21 on caspofungin prophylaxis who died of disseminated Trichosporon asahii during induction therapy for new diagnosis low-risk B-cell acute lymphoblastic leukemia, accompanied by a review of similar cases in the literature. Her case highlights the utility of relatively novel diagnostic modalities and reinforces the need for caution in placing patients on antifungal prophylaxis., Competing Interests: The authors declare no conflict of interest., (Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
17. Endogenous Trichosporon Asahii Retinitis.
- Author
-
Parrozzani R, Marchione G, and Midena G
- Subjects
- Amphotericin B therapeutic use, Antifungal Agents therapeutic use, Blast Crisis pathology, Caspofungin therapeutic use, Cerebrospinal Fluid microbiology, Child, Drug Therapy, Combination, Eye Infections, Fungal diagnosis, Eye Infections, Fungal drug therapy, Fatal Outcome, Female, Fungemia diagnosis, Fungemia drug therapy, Humans, Leukemia, Myeloid, Acute pathology, Retinitis diagnosis, Retinitis drug therapy, Trichosporonosis diagnosis, Trichosporonosis drug therapy, Voriconazole therapeutic use, Basidiomycota isolation & purification, Eye Infections, Fungal microbiology, Fungemia microbiology, Retinitis microbiology, Trichosporonosis microbiology
- Published
- 2022
- Full Text
- View/download PDF
18. Complicated Trichosporon asahii mastoiditis in immunocompetent child.
- Author
-
Al Momani M, Yusef DH, Hamasha D, Hamad MRA, and Farran S
- Subjects
- Antifungal Agents therapeutic use, Child, Female, Humans, Infant, Basidiomycota, Mastoiditis drug therapy, Trichosporon, Trichosporonosis diagnosis, Trichosporonosis drug therapy
- Abstract
Background: Trichosporon asahii is an opportunistic fungus that causes infections in immunosuppressed patients. It is rarely seen in children and immunocompetent hosts. The mortality rates are still high despite early treatment with proper antifungal drugs. Trichosporon asahii mastoiditis in an immunocompetent child makes this case challenging., Case Presentation: This report presents a case of Trichosporon asahii mastoiditis which was complicated by transverse sinus thrombosis, in an otherwise healthy 21-month-old girl, and successfully treated with voriconazole. Trichosporon asahii was isolated, in three different occasions, from ear discharge of an immunocompetent healthy child, who presented with prolonged history of fever and received appropriate dosages of multiple types of antimicrobials as an outpatient but without improvement. After 48 h of starting the Voriconzole; post auricular swelling and ear discharge improved significantly., Conclusion: A high index of clinical and microbiological suspicion is needed for optimal diagnosis of Trichosporon infection. Trichosporon asahii can also cause infection in immunocompetent individual even without previous history of hospitalization or intervention. We emphasize the importance of early pediatric infectious evaluation and intervention., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
19. Insight into the antifungals used to address human infection due to Trichosporon spp.: a scoping review.
- Author
-
Malacrida AM, Salci TP, Negri M, and Svidzinski TI
- Subjects
- Humans, Trichosporon, Antifungal Agents pharmacology, Antifungal Agents therapeutic use, Trichosporonosis diagnosis, Trichosporonosis drug therapy
- Abstract
Trichosporonosis infections have been increasing worldwide. Providing adequate treatment for these infections remains a challenge. This scoping review contains information about potential antifungals to treat this pathology. Using online databases, we found 76 articles published between 2010 and 2020 related to this topic. Classic antifungals, molecules and biomolecules, repositioned drugs and natural products have been tested against species of Trichosporon . Experimental research has lacked depth or was limited to in vitro and in vivo tests, so there are no promising new candidates for the clinical treatment of patients with trichosporonosis. Furthermore, most studies did not present appropriate scientific criteria for drug tests, compromising their quality.
- Published
- 2021
- Full Text
- View/download PDF
20. Invasive Trichosporonosis in a 2-Year-old With Acute Lymphoblastic Leukemia.
- Author
-
Nguyen M, Naeem F, Razzaqi F, and Vijayan V
- Subjects
- Child, Preschool, Humans, Male, Prognosis, Trichosporonosis drug therapy, Trichosporonosis microbiology, Precursor Cell Lymphoblastic Leukemia-Lymphoma complications, Trichosporon isolation & purification, Trichosporonosis diagnosis
- Abstract
Competing Interests: The authors declare no conflict of interest.
- Published
- 2021
- Full Text
- View/download PDF
21. Disseminated Trichosporon asahii infection presenting as eosinophilia in an immunocompetent patient: A case report.
- Author
-
Yang F, Feng J, Wang L, Jiang L, Sheng L, Wu J, Cao Q, and Yi M
- Subjects
- Antifungal Agents therapeutic use, Humans, Basidiomycota, Eosinophilia diagnosis, Eosinophilia drug therapy, Trichosporon, Trichosporonosis diagnosis, Trichosporonosis drug therapy
- Abstract
Trichosporon are naturally found in external environments and are a part of the normal flora of the human skin, respiratory tract, and gastrointestinal tract. Disseminated Trichosporon infection occurs sporadically in patients with immunodeficiency, and is mainly manifested as blood, urine, catheter, and thorax/peritoneum infections, rarely as lymphatic, liver and spleen infections. Elevated blood eosinophil granulocyte from Trichosporon infection have rarely been reported. Here, we report a rare Case of eosinophilia associated with lymphatic and liver and spleen infections due to Trichosporon asahii in an immunocompetent patient. No reports of eosinophilia from Trichosporon infections other than lung, to our knowledge, have been published., Competing Interests: Declaration of competing interest None., (Copyright © 2021 Indian Association of Medical Microbiologists. Published by Elsevier B.V. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
22. Disseminated mucocutaneous trichosporonosis in a patient with histiocytic sarcoma.
- Author
-
Robles-Tenorio A, Rivas-López RA, Bonifaz A, and Tarango-Martínez VM
- Subjects
- Antifungal Agents therapeutic use, Basidiomycota, Humans, Histiocytic Sarcoma drug therapy, Trichosporon, Trichosporonosis diagnosis, Trichosporonosis drug therapy
- Abstract
Trichosporon asahii is the causal agent of trichosporonosis. Patients with immunosuppression or hematological malignancies are at higher risk of infection. Skin and mucosal involvement appear as fast-growing papulonodular lesions and necrotic ulcers. Internal organ dissemination is lethal. Therapeutic success depends on the underlying disease. Here, the authors present the first case of disseminated mucocutaneous trichosporonosis in a patient with a post-mortem diagnosis of histiocytic sarcoma, a rare and aggressive haematolymphoid neoplasm. Regretfully, death occurred despite treatment with liposomal amphotericin B and supportive measures, showcasing the fatality of both diseases., (Copyright © 2021 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
23. Trichosporon dohaense causing life-threatening fungemia in acute leukemia: First case report from India.
- Author
-
Mohanty A, Meena S, Nath UK, Bakliwal A, Kaistha N, and Gupta P
- Subjects
- Adult, Antifungal Agents therapeutic use, Fungemia drug therapy, Humans, India, Leukemia, Myeloid, Acute complications, Leukemia, Myeloid, Acute drug therapy, Leukemia, Myeloid, Acute microbiology, Male, Risk Factors, Trichosporonosis drug therapy, Fungemia diagnosis, Trichosporon pathogenicity, Trichosporonosis blood, Trichosporonosis diagnosis
- Abstract
Competing Interests: None
- Published
- 2021
- Full Text
- View/download PDF
24. Clinical and radiological characteristics of ultrasonic humidifier lung and summer-type hypersensitivity pneumonitis.
- Author
-
Sakamoto S, Furukawa M, Shimizu H, Sekiya M, Miyoshi S, Nakamura Y, Urabe N, Isshiki T, Usui Y, Isobe K, Takai Y, Kurosaki A, Kishi K, and Homma S
- Subjects
- Aged, Alveolitis, Extrinsic Allergic diagnostic imaging, Biomarkers analysis, Biomarkers blood, Blood Cell Count, Bronchoalveolar Lavage Fluid cytology, C-Reactive Protein, Diagnosis, Differential, Female, Humans, Male, Middle Aged, Retrospective Studies, Trichosporonosis diagnostic imaging, Alveolitis, Extrinsic Allergic diagnosis, Tomography, X-Ray Computed, Trichosporonosis diagnosis
- Abstract
Background: Ultrasonic humidifier lung is a rare form of hypersensitivity pneumonitis (HP), and its clinical and radiological features are unclear. This study examined the clinical and radiological characteristics of humidifier lung., Methods: Data from 18 patients with humidifier lung (mean age, 67.3 years) diagnosed during October 2012 through April 2018 were retrospectively reviewed. We compared clinical, laboratory, and CT findings and bronchoalveolar lavage fluid (BALF) characteristics of these patients with those of 19 patients with summer-type HP (mean age, 57.4 years)., Results: Cough and dyspnea were the most common symptoms. White blood cell count and serum C-reactive protein titers were higher for humidifier lung than for summer-type HP. Serum levels of Krebs von den Lungen-6 and surfactant protein D were significantly lower for humidifier lung than for summer-type HP. The most common chest CT findings in humidifier lung were ground-glass opacities (88.9%) and mosaic attenuation (50.0%). Centrilobular ground glass nodules were less common in humidifier lung than in summer-type HP (27.8% vs 63.1%; P = 0.043). Peribronchovascular or subpleural nonsegmental consolidation was more frequent in humidifier lung than in summer-type HP (44.4% vs 5.3%; P = 0.013). Lymphocyte fractions in BALF specimens were significantly lower for humidifier lung than for summer-type HP (37.3% vs 69.0%; P < 0.001). Neutrophil fractions were higher for humidifier lung, but the difference was not significant (22.1% vs 8.1%; P = 0.153). The CD4/8 ratio was higher for humidifier lung than for summer-type HP (1.7 vs 0.8; P = 0.003)., Conclusions: The clinical and radiological characteristics of humidifier lung differ from those of summer-type HP., (Copyright © 2020 Elsevier Ltd. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
25. A rare case of Trichosporon mycotoxinivorans and Cryptococcus neoformans co-infection in lung.
- Author
-
Sadamatsu H, Takahashi K, Tashiro H, Ogusu S, Haraguchi T, Nakashima C, Nakamura T, and Sueoka-Aragane N
- Subjects
- Aged, Antifungal Agents therapeutic use, Biopsy, Bronchoalveolar Lavage Fluid microbiology, Coinfection drug therapy, Coinfection microbiology, Cryptococcosis drug therapy, Fatal Outcome, Female, Fluconazole therapeutic use, Humans, Lung diagnostic imaging, Lung pathology, Lung Diseases, Fungal diagnosis, Lung Diseases, Fungal drug therapy, Radiography, Treatment Outcome, Trichosporonosis drug therapy, Coinfection diagnosis, Cryptococcosis diagnosis, Cryptococcus neoformans isolation & purification, Trichosporon isolation & purification, Trichosporonosis diagnosis
- Abstract
A 70-year-old woman with liver cirrhosis caused by primary biliary cirrhosis and rheumatoid arthritis was found to have multiple pulmonary nodular shadows in the right middle and lower lung fields on chest radiography. The multiple pulmonary nodules and masses rapidly increased over 2 months. Trichosporon mycotoxinivorans and Cryptococcus neoformans were identified in brushing specimens, bronchial lavage, and transbronchial lung biopsy specimens. The patient was diagnosed as having a co-infection of the lung with T. mycotoxinivorans and C. neoformans, and was treated with fluconazole. Although the pulmonary shadows were under control with treatment, she died 5 months later due to liver failure. We report herein a rare case of co-infection of the lung with T. mycotoxinivorans and C. neoformans., Competing Interests: Declaration of Competing Interest All authors declare that there are no conflicts of interest regarding the publication of this paper., (Copyright © 2020 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
26. A case report of catheter-related bloodstream infection due to Trichosporon coremiiforme in a patient with secondary neutropenia to HIV.
- Author
-
Monzani V, Córdoba S, Vivot M, Arias B, Vivot W, Szusz W, Castellaro P, Appendino A, and Taverna CG
- Subjects
- AIDS-Related Opportunistic Infections blood, AIDS-Related Opportunistic Infections diagnosis, AIDS-Related Opportunistic Infections drug therapy, AIDS-Related Opportunistic Infections microbiology, Amphotericin B administration & dosage, Antitubercular Agents administration & dosage, Bacteremia diagnosis, Bacteremia drug therapy, Bacteremia microbiology, Catheter-Related Infections complications, Catheter-Related Infections drug therapy, Catheter-Related Infections microbiology, Central Venous Catheters adverse effects, Central Venous Catheters microbiology, Drug Therapy, Combination, Female, Fluconazole administration & dosage, HIV, HIV Infections diagnosis, HIV Infections microbiology, Humans, Immunocompromised Host, Middle Aged, Neutropenia diagnosis, Neutropenia microbiology, Neutropenia virology, Trichosporon isolation & purification, Trichosporonosis drug therapy, Trichosporonosis etiology, Tuberculosis, Pulmonary complications, Tuberculosis, Pulmonary drug therapy, Tuberculosis, Pulmonary microbiology, Catheter-Related Infections diagnosis, HIV Infections complications, Neutropenia complications, Trichosporonosis diagnosis
- Abstract
Here, we describe an invasive infection due to Trichosporon coremiiforme in an HIV positive patient with neutropenia. The strain was first erroneously identified as Trichosporon asahii by conventional methods, but correctly identified by mass spectrometry using matrix-assisted laser desorption/ionization time-of-flight technology (MALDI-TOF MS) and ribosomal DNA sequencing. The infection was successfully resolved after antifungal treatment with amphotericin B and fluconazole. This case report is a contribution to the study of T. coremiiforme infections and reinforces its relevance as a species capable of causing invasive human infection in immunocompromised patients and also contributes to the study of its susceptibility profile against antifungal drugs., (Copyright © 2019 Elsevier Masson SAS. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
27. Cutaneotrichosporon (Trichosporon) debeurmannianum associated with a subcutaneous mycotic cyst successfully treated with voriconazole.
- Author
-
Noy ML, Abdolrasouli A, Borman AM, Fraser M, Francis N, Moore LSP, and Merika EE
- Subjects
- Adult, Cysts microbiology, Dermatomycoses diagnosis, Dermatomycoses microbiology, Humans, Male, Trichosporonosis diagnosis, Trichosporonosis microbiology, Antifungal Agents therapeutic use, Dermatomycoses drug therapy, Trichosporon isolation & purification, Trichosporonosis drug therapy, Voriconazole therapeutic use
- Published
- 2020
- Full Text
- View/download PDF
28. Invasive Hepatobiliary Trichosporon asahii Infection in a Child With Autoimmune Cholangitis.
- Author
-
Noailly Charny PA, Rohmer B, Collardeau-Frachon S, Gillet Y, Dupont D, Wallon M, Lachaux A, and Rabodonirina M
- Subjects
- Antifungal Agents therapeutic use, Child, Cholangitis pathology, Cholecystectomy, Female, Gallbladder microbiology, Gallbladder pathology, Humans, Immunoglobulin G blood, Immunoglobulin G4-Related Disease, Trichosporon pathogenicity, Trichosporonosis diagnosis, Trichosporonosis microbiology, Trichosporonosis pathology, Voriconazole therapeutic use, Autoimmune Diseases complications, Cholangitis complications, Trichosporonosis complications
- Published
- 2019
- Full Text
- View/download PDF
29. Case of summer-type hypersensitivity pneumonitis complicated with IgA nephropathy.
- Author
-
Maetani T, Shima H, Shiraishi Y, and Marumo S
- Subjects
- Alveolitis, Extrinsic Allergic drug therapy, Alveolitis, Extrinsic Allergic immunology, Antibodies, Fungal, Bronchoscopy, Cough, Dyspnea etiology, Glomerulonephritis, IGA drug therapy, Glomerulonephritis, IGA immunology, Housing, Humans, Immunoglobulin A immunology, Male, Middle Aged, Radiography, Thoracic, Seasons, Treatment Outcome, Trichosporonosis drug therapy, Trichosporonosis immunology, Trichosporonosis physiopathology, Adrenal Cortex Hormones therapeutic use, Air Conditioning adverse effects, Alveolitis, Extrinsic Allergic microbiology, Dyspnea microbiology, Glomerulonephritis, IGA microbiology, Trichosporonosis diagnosis
- Abstract
Association between pulmonary disease and IgA nephropathy (IgAN) has been previously reported. However, no association has been reported between hypersensitivity pneumonitis (HP) and IgAN. Here, we report about a patient with no particular medical history, who experienced worsening dyspnoea in the course of 1 month, with ground-glass opacity on chest CT and no improvement after antibiotic therapy. The patient was diagnosed as having HP based on the history of antigen exposure, detection of Trichosporon asahii -specific antibodies and bronchoscopy findings. Concomitantly, findings of renal biopsy revealed the IgAN diagnosis. The patient underwent corticosteroid therapy, with good outcomes for both HP and IgAN. This is the first report in the literature to describe summer-type HP complicated with IgAN., Competing Interests: Competing interests: None declared., (© BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2019
- Full Text
- View/download PDF
30. Molecular identification and biological characteristic analysis of an Apiotrichum mycotoxinivorans (formerly Trichosporon mycotoxinivorans) strain isolated from sputum specimens of a pediatric patient with pneumonia.
- Author
-
Peng L, Jiang YQ, Jiang GM, Ou JY, Zeng LT, Zhang HH, Chen DQ, and Jiang YT
- Subjects
- Antifungal Agents pharmacology, Child, Preschool, DNA, Fungal genetics, Female, Humans, Mycological Typing Techniques, Phylogeny, Trichosporon drug effects, Trichosporonosis microbiology, Pneumonia microbiology, Sputum microbiology, Trichosporon classification, Trichosporon isolation & purification, Trichosporonosis diagnosis
- Abstract
Apiotrichum mycotoxinivorans (formerly Trichosporon mycotoxinivorans) has long been used to degrade fungal toxins in livestock feed. However, clinic reports about this type of fungus are rare. In this study, we report the morphology, biochemistry, and molecular characteristics of an A. mycotoxinivorans strain isolated from a pediatric patient with congenital ventricular septal defect and pneumonia. A female patient, 26 months old, presented with congenital ventricular septal defect. Pulmonary infection symptoms were observed after the patient received cardiac repair surgery. Sputum bacterial and fungal cultures were positive for Elizabethkingia anophelis and a fungus, which was not readily identifiable using biochemical identification, or MALDI-TOF MS analysis. The strain was finally identified as A. mycotoxinivorans using amplification and sequencing of the D1/D2 region of 26S rDNA, ITS, and IGS1. Antifungal susceptibility test results suggested that fluconazole or voriconazole may be an appropriate choice for antifungal therapy. A biodegradability of ochratoxin A was considered as a characteristic of the fungal strain. Our results support the existing evidence that A. mycotoxinivorans is an opportunistic pathogen for human beings. Nucleic acid analysis allows for the accurate identification of the species in instances where conventional identification methods such as biochemical testing and MALDI-TOF MS may be unsuccessful., (Copyright © 2019. Published by Elsevier Masson SAS.)
- Published
- 2019
- Full Text
- View/download PDF
31. Rapid and Simple Detection of Trichosporon asahii by Optimized Colony PCR.
- Author
-
Zhang D, Lu X, Liao Y, Xia Z, Peng Z, Yang X, and Yang R
- Subjects
- Humans, DNA, Fungal genetics, DNA, Ribosomal genetics, Polymerase Chain Reaction, Trichosporon genetics, Trichosporonosis diagnosis, Trichosporonosis genetics
- Abstract
Trichosporon asahii is the major pathogen causing invasive trichosporonosis. Conventional methods of its detection are time-consuming or costly and often require complex DNA extraction and purification steps, which hinders rapid clinical diagnosis. In this study, we evaluated colony PCR, which directly uses colonies or trace clinical samples as the template for amplification, for rapid detection of T. asahii infection. Four methods, namely, direct colony, freeze-thaw, glass beads, and enzymolysis, were compared to select the best DNA extraction strategy. We subsequently designed and screened species-specific primers targeting the intergenic spacer 1 (IGS1) of the ribosomal DNA of T. asahii and used them to detect mock infection clinical samples. The species-specific colony PCR based on glass beads proved advantageous, with short procedure time (154.8 ± 0.6 min), good sensitivity (detection limit, 10
2 CFU/mL), and specificity for T. asahii , indicating that this method can be used for the rapid and simple identification of clinical samples of T. asahii infection.- Published
- 2019
- Full Text
- View/download PDF
32. Recurrent fungal infections in a Chinese patient with CARD9 deficiency and a review of 48 cases.
- Author
-
Quan C, Li X, Shi RF, Zhao XQ, Xu H, Wang B, Wang XP, Hu WG, Cao H, and Zheng J
- Subjects
- Candida albicans immunology, Candida albicans isolation & purification, Candidiasis, Chronic Mucocutaneous genetics, Candidiasis, Chronic Mucocutaneous immunology, Candidiasis, Chronic Mucocutaneous microbiology, DNA Mutational Analysis, Frameshift Mutation, Humans, Male, Recurrence, Skin microbiology, Trichosporon immunology, Trichosporon isolation & purification, Trichosporonosis genetics, Trichosporonosis immunology, Trichosporonosis microbiology, Young Adult, CARD Signaling Adaptor Proteins genetics, Candidiasis, Chronic Mucocutaneous diagnosis, Genetic Predisposition to Disease, Trichosporonosis diagnosis
- Abstract
Deficiency of CARD9 (caspase recruitment domain-containing protein 9) has been reported in individuals with recurrent and invasive fungal infections. We report on a patient who first had Trichosporon asahii affecting the skin then Candida albicans infections involving the digestive tract and knee joint, along with elevated serum IgE. After stimulation with C. albicans, peripheral blood mononuclear cells of this patient produced less tumour necrosis factor-α, interferon-γ and interleukin-17 than those of healthy controls. Furthermore, the serum IgE levels of this patient were positively correlated with the severity of fungal infection during the course of treatment. Sanger sequencing identified one homozygous frameshift mutation (p.D274fsX60) in CARD9. We further performed a review including 48 cases with CARD9 deficiency. According to the data published previously, CARD9-deficient patients demonstrated obviously elevated IgE in serum (median 1300 IU mL
-1 ), which could distinguish them from otherwise healthy people with fungal infections (area under the curve 0·94, P < 0·001). Patients carrying the mutations Q289X and Q295X had a higher mortality rate (24% vs. 0%, P < 0·05). Patients with the mutations R18W, R35Q, R70W, G72S or Y91H in the CARD domain, and the nonsense mutation Q295X in the coiled-coil domain, seemed to be more prone to Candida infections (90% vs. 20%, P < 0·005) and central nervous system infections (60% vs. 12%, P < 0·005)., (© 2018 British Association of Dermatologists.)- Published
- 2019
- Full Text
- View/download PDF
33. Disseminated Trichosporon asahii infection in a patient with acute myeloid leukemia.
- Author
-
Cardenas-de la Garza JA, Ancer-Arellano J, Cuellar-Barboza A, Saenz-Ibarra B, Ocampo-Garza SS, Barboza-Quintana O, Gallardo-Rocha A, Vera-Cabrera L, Ocampo-Candiani J, and Welsh O
- Subjects
- Amphotericin B therapeutic use, Antifungal Agents therapeutic use, Biopsy, Fatal Outcome, Female, Fungemia drug therapy, Fungemia microbiology, Fungemia prevention & control, Humans, Immunocompromised Host, Itraconazole therapeutic use, Middle Aged, Skin microbiology, Skin pathology, Treatment Failure, Trichosporonosis drug therapy, Trichosporonosis microbiology, Trichosporonosis prevention & control, Antibiotic Prophylaxis methods, Fungemia diagnosis, Leukemia, Myeloid, Acute immunology, Trichosporon isolation & purification, Trichosporonosis diagnosis
- Published
- 2019
- Full Text
- View/download PDF
34. A case of Trichosporon asahii urinary tract infection in a frail elderly patient.
- Author
-
Acampora N, Frizza A, Brau F, Torelli R, Vella A, De Carolis E, and Fantoni M
- Subjects
- Aged, 80 and over, Frail Elderly, Hematuria, Humans, Invasive Fungal Infections diagnosis, Male, Mycoses diagnosis, Urinary Tract Infections diagnosis, Invasive Fungal Infections microbiology, Mycoses microbiology, Trichosporon isolation & purification, Trichosporonosis diagnosis, Urinary Tract Infections microbiology
- Abstract
Trichosporon urinary tract infection (UTI) is an unusual emerging infection, caused mostly by Trichosporon asahii, described especially in hospitalized patients. To date the interpretation and management of Trichosporon positive urinary culture remains a diagnostic and therapeutic dilemma for which there are no precise indications, and the challenge can be even more complicated in comorbid frail elderly patients. Triazoles are known to be the most effective antifungal drugs but can raise concerns about pharmacological interaction. We report a case of Trichosporon asahii nosocomial UTI in an elderly patient.
- Published
- 2019
35. Disseminated trichosporonosis with atypical histologic findings in a patient with acute lymphocytic leukemia.
- Author
-
Galligan ER, Fix L, Husain S, Zachariah P, Yamashiro DJ, and Lauren CT
- Subjects
- Adolescent, Humans, Male, Dermatomycoses diagnosis, Dermatomycoses drug therapy, Dermatomycoses pathology, Precursor Cell Lymphoblastic Leukemia-Lymphoma diagnosis, Precursor Cell Lymphoblastic Leukemia-Lymphoma drug therapy, Precursor Cell Lymphoblastic Leukemia-Lymphoma pathology, Trichosporonosis diagnosis, Trichosporonosis drug therapy, Trichosporonosis pathology
- Abstract
We report a case of disseminated Trichosporon asahii in a patient on systemic antifungal therapy who presented with multiple cutaneous nodules suggestive of fungal infection. Histologic features resembled neutrophilic eccrine hidradenitis but staining with periodic acid-Schiff and Gomori methenamine silver confirmed the clinical diagnosis. This case highlights the importance of maintaining suspicion for trichosporonosis and contextualizing histologic findings within the underlying clinical picture., (© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2019
- Full Text
- View/download PDF
36. Trichosporon inkin meningitis in Northeast Brazil: first case report and review of the literature.
- Author
-
Milan EP, Silva-Rocha WP, de Almeida JJS, Fernandes TUG, de Araújo Prudente AL, de Azevedo MF, Francisco EC, de Azevedo Melo AS, Colombo AL, and Chaves GM
- Subjects
- Amphotericin B therapeutic use, Antifungal Agents therapeutic use, Brazil, DNA, Ribosomal, Female, Humans, Immunocompromised Host, Meningitis, Fungal diagnosis, Meningitis, Fungal microbiology, Microbial Sensitivity Tests, Middle Aged, Sequence Analysis, DNA, Trichosporon genetics, Trichosporonosis diagnosis, Voriconazole therapeutic use, Meningitis, Fungal drug therapy, Trichosporon drug effects, Trichosporon pathogenicity, Trichosporonosis drug therapy
- Abstract
Background: Trichosporon species may colonize the skin, respiratory tract and gastrointestinal tract of human beings. The yeast is recognized as etiological agent of white piedra, a superficial mycosis. Nevertheless, immunocompromised hosts may develop invasive Trichosporonosis. Central nervous system trichosporonosis is a very rare clinical manifestation. In fact, only a few cases have been published in the literature and none of them was caused by Trichosporon inkin., Case Presentation: Here we report the first clinical case of meningoencephalitis due to this species in a female previously healthy patient under corticosteroids and antibiotics therapy for several months. She was submitted to an invasive procedure to remove a left sided acoustic neuroma and further developed a cerebrospinal fistula. After some days of the procedure, she presented a predominantly and intensive occipital holocranial headache, followed by vomiting, hyporexia, weight loss, asthenia, irritability, difficulty to concentrate and rotator vertigo. The patient further developed a cerebrospinal fistula in the occipital region and was submitted to a surgical correction. After several months of clinical interventions, she was diagnosed with CNS Trichosporonosis, after Magnetic Resonance Imaging and positive microbiological cultures obtained within two different occasions (2 weeks apart). Despite the antifungal therapy with Amphotericin B and Voriconazole, the patient did not survive., Conclusions: Despite CNS Fungal infections are mostly due to Cryptococcus spp., other emergent yeasts, such as T. inkin may be considered as a likely etiological agent. This is the first case report of CNS Trichosporonosis, where species identification was performed with rDNA sequencing.
- Published
- 2018
- Full Text
- View/download PDF
37. Trichosporonosis in Pediatric Patients With a Hematologic Disorder.
- Author
-
Foster CE, Edwards MS, Brackett J, Schady DA, Healy CM, and Baker CJ
- Subjects
- Adolescent, Amphotericin B therapeutic use, Antifungal Agents therapeutic use, Child, Drug Therapy, Combination, Echinocandins therapeutic use, Female, Humans, Invasive Fungal Infections drug therapy, Invasive Fungal Infections microbiology, Leukemia, Myeloid, Acute immunology, Lipopeptides therapeutic use, Male, Micafungin, Neutropenia complications, Opportunistic Infections drug therapy, Opportunistic Infections microbiology, Trichosporonosis drug therapy, Trichosporonosis microbiology, Voriconazole therapeutic use, Immunocompromised Host, Invasive Fungal Infections diagnosis, Opportunistic Infections diagnosis, Precursor Cell Lymphoblastic Leukemia-Lymphoma immunology, Trichosporonosis diagnosis
- Abstract
Background: Trichosporonosis is an emerging and often fatal opportunistic fungal infection in immunocompromised patients, particularly those with hematologic malignancy, but data in children are lacking., Methods: We report here 3 cases of invasive infection caused by Trichosporon asahii in pediatric patients with acute lymphoblastic leukemia at Texas Children's Hospital in Houston, Texas. We also conducted a literature review and identified 16 additional reports of pediatric patients with invasive T asahii infection and an underlying malignant or nonmalignant hematologic disorder., Results: Of the 19 cases of invasive T asahii infection, the most commonly reported underlying hematologic disorder was acute lymphoblastic leukenia (47%), followed by acute myelogenous leukemia (21%). Most of the patients (94%) had neutropenia, defined as an absolute neutrophil count of <500 cells/mm3. Antifungal prophylaxis information was available in 6 of the 19 cases, and micafungin use was reported in 5 cases. Treatment regimens frequently included voriconazole monotherapy (47%) or the combination of an azole antifungal with amphotericin B (35%). The mortality rate was 58%., Conclusions: Recognizing that echinocandins, which are increasingly used for prophylaxis in patients with a hematologic malignancy, are not active against Trichosporon species is of critical importance. The recommended first-line therapy for trichosporonosis is voriconazole, but successful outcome depends largely on the underlying immune status of the host.
- Published
- 2018
- Full Text
- View/download PDF
38. Detection of some new Trichosporon species from the dystrophied nails of three female members of a family from North Indian State of Jammu and Kashmir.
- Author
-
Kotwal S, Sumbali G, Sharma S, and Kaul S
- Subjects
- Adolescent, Adult, Cluster Analysis, DNA, Fungal chemistry, DNA, Fungal genetics, DNA, Ribosomal chemistry, DNA, Ribosomal genetics, DNA, Ribosomal Spacer chemistry, DNA, Ribosomal Spacer genetics, Female, Genes, rRNA, Humans, India, Microbiological Techniques, Microscopy, Nails microbiology, Phylogeny, RNA, Fungal genetics, RNA, Ribosomal, 18S genetics, RNA, Ribosomal, 28S genetics, Sequence Analysis, DNA, Trichosporon classification, Trichosporon genetics, Family Health, Nails pathology, Onychomycosis diagnosis, Onychomycosis pathology, Trichosporon isolation & purification, Trichosporonosis diagnosis, Trichosporonosis pathology
- Abstract
Dermatophytes are considered as the main pathogens responsible for onychomycosis, but recently successive isolations of yeast-like fungi from the infected nails has led to consider these also as primary agents of nail infections. Trichosporon species which are non-candidal, basidiomycetous, yeast-like, anamorphic fungi are commonly isolated from soil but they are also emerging as important etiological agents of onychomycosis. Three species of Trichosporon viz., T. asahii, T. asteroides and T. faecale were isolated from the infected nails of three female members of a family from district Doda of Jammu and Kashmir State. Among the isolated species of Trichosporon, T. asahii was recovered from the nail samples of all the three members, thus confirming its recognition as a main pathogenic species of onychomycosis. So far, there is no report of T. asteroides and T. faecale causing onychomycosis and hence they constitute new additions to the list of onychomycotic fungi. Some of the predisposing factors like low socio-economic condition, poor hygiene, frequent exposure of finger nails to water and dirt, climatic conditions and nail trauma were observed to be the main causes of nail infection in these patients. However, a link between the pathogenic genus and the genetic makeup of the patients is also probable., (© 2018 Blackwell Verlag GmbH.)
- Published
- 2018
- Full Text
- View/download PDF
39. Cutaneotrichosporon (Trichosporon) debeurmannianum: A Rare Yeast Isolated from Blood and Urine Samples.
- Author
-
Nath R, Sargiary P, Borkakoty B, and Parida P
- Subjects
- Adolescent, Adult, Antifungal Agents pharmacology, Child, Preschool, Cluster Analysis, DNA, Fungal chemistry, DNA, Fungal genetics, DNA, Ribosomal Spacer chemistry, DNA, Ribosomal Spacer genetics, Disk Diffusion Antimicrobial Tests, Female, Fluconazole pharmacology, Humans, India, Infant, Newborn, Male, Middle Aged, Phylogeny, Sequence Analysis, DNA, Tertiary Care Centers, Trichosporon drug effects, Trichosporon genetics, Voriconazole pharmacology, Blood microbiology, Trichosporon classification, Trichosporon isolation & purification, Trichosporonosis diagnosis, Trichosporonosis microbiology, Urine microbiology
- Abstract
Cutaneotrichosporon (Trichosporon) debeurmannianum is a rarely isolated yeast from clinical samples. Nine isolates of this yeast were identified from clinical samples within a period of 3 years from June 2012 to May 2015. These isolates were from blood and urine samples sent to a clinical mycology laboratory of a tertiary care hospital in Assam, North East India. Clinically, the patients were diagnosed as septicemia and urinary tract infection. The age of the patients ranged from 2 to 50 years. Identification was made by sequencing the ITS region of ribosomal RNA gene. Antifungal susceptibility test by disk diffusion method (CLSI, M44-A) showed all the isolates to be sensitive to fluconazole and voriconazole. Vitek 2 compact commercial yeast identification system misidentified this yeast as Cryptococcus laurentii and low discrimination Cryptococcus laurentii/Trichosporon mucoides. This species was originally named as Trichosporon debeurmannianum. In 2015, this yeast has been included into new genera Cutaneotrichosporon based on an integrated phylogenetic classification of the Tremellomycetes. To the best of our knowledge, this is the first report of identification of this species from blood and urine samples of clinically suspected cases. We are reporting these isolates because of their rarity in clinical samples. The pathogenic potential and epidemiological relevance of this yeast remains to be seen.
- Published
- 2018
- Full Text
- View/download PDF
40. Systemic trichosporonosis mimicking disseminated varicella zoster viral infection during blinatumomab therapy.
- Author
-
Chan TSY and Kwong YL
- Subjects
- Adult, Antibodies, Bispecific therapeutic use, Antifungal Agents therapeutic use, Antineoplastic Agents, Immunological therapeutic use, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Antiviral Agents therapeutic use, Chemotherapy-Induced Febrile Neutropenia complications, Female, Humans, Precursor Cell Lymphoblastic Leukemia-Lymphoma complications, Precursor Cell Lymphoblastic Leukemia-Lymphoma drug therapy, Recurrence, Salvage Therapy, Trichosporonosis drug therapy, Trichosporonosis etiology, Antibodies, Bispecific adverse effects, Antineoplastic Agents, Immunological adverse effects, Diagnosis, Differential, Trichosporonosis diagnosis, Varicella Zoster Virus Infection diagnosis
- Published
- 2018
- Full Text
- View/download PDF
41. Fatal disseminated Trichosporon asahii fungemia in a child with acute lymphoblastic leukemia and a morbilliform eruption.
- Author
-
Nguyen JK, Schlichte MJ, Schady D, and Pourciau CY
- Subjects
- Antifungal Agents therapeutic use, Child, Drug Eruptions etiology, Febrile Neutropenia complications, Fungemia complications, Fungemia drug therapy, Humans, Immunocompromised Host, Male, Precursor Cell Lymphoblastic Leukemia-Lymphoma complications, Trichosporonosis complications, Trichosporonosis drug therapy, Voriconazole therapeutic use, Antineoplastic Agents adverse effects, Fungemia diagnosis, Precursor Cell Lymphoblastic Leukemia-Lymphoma drug therapy, Trichosporon isolation & purification, Trichosporonosis diagnosis
- Abstract
Trichosporonosis is a rare, life-threatening, opportunistic fungal infection that affects immunocompromised individuals with neutropenia, particularly those with underlying hematologic malignancies. We present the case of a 10-year-old boy with acute lymphoblastic leukemia who developed a diffuse, morbilliform eruption in the setting of fever and pancytopenia. He was found to have Trichosporon asahii fungemia with widespread visceral dissemination, and his condition rapidly deteriorated despite treatment. It is important to consider trichosporonosis in the evaluation of a critically ill individual with neutropena and a rash, because the initial cutaneous presentation may appear benign and delayed therapy results in death., (© 2017 Wiley Periodicals, Inc.)
- Published
- 2018
- Full Text
- View/download PDF
42. An Unusual Infection in a Child with Congenital Heart Disease - Trichosporon asahii Infection with Rapid Diagnosis by 18s Ribonucleic Acid (RNA).
- Author
-
Grignani R, Koay ES, Quek SC, and Harkensee C
- Subjects
- Blalock-Taussig Procedure adverse effects, Child, Heart Defects, Congenital complications, Humans, Klippel-Feil Syndrome complications, Male, Postoperative Complications etiology, Trichosporonosis etiology, Heart Defects, Congenital surgery, Postoperative Complications diagnosis, RNA, Fungal isolation & purification, RNA, Ribosomal, 18S isolation & purification, Trichosporon isolation & purification, Trichosporonosis diagnosis
- Published
- 2017
43. Emergence of Trichosporon mycotoxinivorans (Apiotrichum mycotoxinivorans) invasive infections in Latin America.
- Author
-
Almeida JN Jr, Francisco EC, Barberino MGMA, Silva LVRFD Filho, Brandão OM, Colombo AL, and Padovan ACB
- Subjects
- Adolescent, Adult, Antifungal Agents pharmacology, Biofilms growth & development, Brazil epidemiology, Genotype, Humans, Latin America, Male, Microbial Sensitivity Tests, Trichosporon classification, Trichosporon drug effects, Trichosporonosis epidemiology, Trichosporonosis microbiology, Trichosporon genetics, Trichosporonosis diagnosis
- Abstract
We report the first two cases of Trichosporon mycotoxinivorans infections in Latin America. We also conducted a literature review and a microbiological investigation, including that of clinical and environmental isolates. A 30-year-old man with chronic renal failure had disseminated infection after dialysis and a 15-year-old boy with cystic fibrosis (CF) had pulmonary exacerbations with positive respiratory samples. A review of the relevant literature revealed that deep-seated infections were related to immunosuppression or invasive devices, while most of the CF patients showed a decline in lung function after positive cultures. Phylogenetic analyses revealed three distinct circulating genotypes. MALDI-TOF mass spectrometry analysis showed similar spectral profiles and correctly identified all strains/isolates. Biofilm production was documented in a bloodstream isolate and biofilm-producing cells showed high minimum inhibitory concentrations against antifungals.
- Published
- 2017
- Full Text
- View/download PDF
44. Trichosporon asteroides Isolated from Cutaneous Lesions of a Suspected Case of "paracoccidioidomycosis ceti" in a Bottlenose Dolphin (Tursiops truncatus).
- Author
-
Ueda K, Nakamura I, Itano EN, Takemura K, Nakazato Y, and Sano A
- Subjects
- Animals, Biopsy, Cluster Analysis, DNA, Fungal chemistry, DNA, Fungal genetics, DNA, Ribosomal Spacer chemistry, DNA, Ribosomal Spacer genetics, Dermatomycoses diagnosis, Dermatomycoses pathology, Female, Japan, Mycological Typing Techniques, Phylogeny, Sequence Analysis, DNA, Trichosporon genetics, Trichosporonosis diagnosis, Trichosporonosis pathology, Bottle-Nosed Dolphin, Dermatomycoses veterinary, Trichosporon classification, Trichosporon isolation & purification, Trichosporonosis veterinary
- Abstract
"Paracoccidioidomycosis ceti" is a rare zoonotic fungal infection affecting dolphins and is endemic worldwide. The causative agents are Paracoccidioides species; however, it is impossible to isolate the fungal species. We isolated Trichosporon asteroides from multifocal, irregularly raised skin lesions on a female bottlenose dolphin (Tursiops truncatus) captured off coast of Japan, which was suspected to have "paracoccidioidomycosis ceti." An abundance of round, yeast-like cells was detected in a potassium hydroxide direct-mount specimen of the skin samples; however, nested PCR targeting the partial sequence of 43-kDa glycoprotein-coding gene correspondent to Paracoccidioides sp. was negative. Biopsied tissue samples were cultured on brain heart infusion agar plates supplemented with chloramphenicol, 1% yeast extract, and 4% sodium chloride (4% NaCl-BHI), on Mycosel agar with 4% sodium chloride (4% NaCl-Mycosel), and on potato dextrose agar supplemented with chloramphenicol (CPDA) at 35 °C for 4 weeks. Cream-colored and wrinkled colonies consisting of hyphae and arthroconidia grew on 4% NaCl-BHI and CPDA, while film-like colonies composed of arthroconidia and round yeast-like cells developed on 4% NaCl-Mycosel. Although these primary cultures resembled fresh isolates of P. brasiliensis, they were identified as Trichosporon asteroides based on routine mycological studies and the internal transcribed spacer regions of ribosomal RNA sequences. The results suggested that trichosporonosis caused by T. asteroides might remain latent among cases of "paracoccidioidomycosis ceti" diagnosed without cultures and molecular biological analysis.
- Published
- 2017
- Full Text
- View/download PDF
45. Trichosporon inkin disseminated infection.
- Author
-
Thion LA, Coutard A, Eloy O, and Bruneel F
- Subjects
- Adult, Antifungal Agents therapeutic use, Humans, Immunocompromised Host, Lung diagnostic imaging, Male, Mass Spectrometry, Tomography, X-Ray Computed, Voriconazole therapeutic use, Trichosporon isolation & purification, Trichosporonosis blood, Trichosporonosis diagnosis, Trichosporonosis drug therapy, Trichosporonosis microbiology
- Published
- 2017
- Full Text
- View/download PDF
46. Multiple Brain Abscesses Caused by Trichosporon inkin in a Patient with X-Linked Chronic Granulomatous Disease (CGD) Successfully Treated with Antifungal Therapy.
- Author
-
Hajjar J, Restrepo A, Javeri H, Wiederhold NP, Papanastassiou AM, and Patterson TF
- Subjects
- Brain Abscess surgery, Child, Granulomatous Disease, Chronic genetics, Head surgery, Humans, Infant, Male, NADPH Oxidase 2 genetics, Young Adult, Antifungal Agents therapeutic use, Brain Abscess diagnosis, Granulomatous Disease, Chronic diagnosis, Head diagnostic imaging, Trichosporon physiology, Trichosporonosis diagnosis
- Published
- 2017
- Full Text
- View/download PDF
47. An Unusual Case of White Piedra Due to Trichosporon inkin Mimicking Trichobacteriosis.
- Author
-
Zhuang K, Ran X, Dai Y, Tang J, Yang Q, Pradhan S, and Ran Y
- Subjects
- Adult, Antifungal Agents therapeutic use, DNA, Fungal chemistry, DNA, Fungal genetics, DNA, Ribosomal Spacer chemistry, DNA, Ribosomal Spacer genetics, Diagnosis, Differential, Enzymes analysis, Histocytochemistry, Humans, Male, Microbiological Techniques, Microscopy, Piedra microbiology, Sequence Analysis, DNA, Treatment Outcome, Trichosporon classification, Trichosporon genetics, Trichosporonosis microbiology, Piedra etiology, Piedra pathology, Trichosporon isolation & purification, Trichosporonosis diagnosis, Trichosporonosis pathology
- Abstract
White piedra is a superficial mycosis characterized by soft, white-to-tan, irregular nodules attached to the hair shafts. A 36-year-old man presented with small lumps in his pubic hair, without any other symptoms. The clinical features were suggestive of trichobacteriosis. Pathology analysis of the infected hair revealed that the concretions surrounding the hair shaft were full of fungal elements, parts of which had invaded into the cuticle. Culture on Sabouraud dextrose agar grew creamy, yellow-white colonies identified as Trichosporon inkin by the sequence of the nuclear ribosomal intergenic spacer region. The condition was treated by shaving the pubic hair and administering antifungal therapy (oral itraconazole and topical ketoconazole).
- Published
- 2016
- Full Text
- View/download PDF
48. Clinical outcomes in cystic fibrosis patients with Trichosporon respiratory infection.
- Author
-
Esther CR Jr, Plongla R, Kerr A, Lin FC, and Gilligan P
- Subjects
- Adolescent, Child, Female, Forced Expiratory Volume, Humans, Male, Respiratory Function Tests methods, Respiratory Function Tests statistics & numerical data, Thailand epidemiology, Treatment Outcome, Young Adult, Antifungal Agents therapeutic use, Chryseobacterium isolation & purification, Chryseobacterium pathogenicity, Cystic Fibrosis diagnosis, Cystic Fibrosis epidemiology, Cystic Fibrosis microbiology, Cystic Fibrosis physiopathology, Respiratory Tract Infections diagnosis, Respiratory Tract Infections drug therapy, Respiratory Tract Infections physiopathology, Trichosporon isolation & purification, Trichosporon pathogenicity, Trichosporonosis diagnosis, Trichosporonosis drug therapy, Trichosporonosis physiopathology
- Abstract
Background: Relationships between clinical outcomes and novel respiratory pathogens such as Trichosporon are not well understood., Methods: Respiratory cultures from CF patients were screened for novel pathogens Trichosporon and Chryseobacterium as well as other pathogens over 28months. Relationships between microbiologic and clinical data were assessed using univariate and multivariate methods., Results: Of 4934 respiratory cultures from 474 CF patients, 37 cultures from 10 patients were Trichosporon positive. Patients with positive Trichosproron cultures had a greater decline in FEV1 over time (-3.9%/year vs. -1.3%/year, p<0.05), whereas Chryseobacterium did not influence lung function. These findings were confirmed in multivariate analyses that included age, gender, and other common pathogens as confounders. Treatment of Trichosporon infected patients was associated with improved lung function., Conclusions: Trichosporon can be recovered from a small but clinically meaningful fraction of CF patients. The presence of Trichosporon, but not Chryseobacterium, is associated with greater declines in lung function., (Copyright © 2016 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
49. Trichosporon loubieri Fungemia in a 39-Year-Old Caucasian Woman With B-Cell Lymphoblastic Leukemia.
- Author
-
Bhaskaran A, Obeid KM, Arbefeville S, and Ferrieri P
- Subjects
- Adult, Basidiomycota, Female, Fungemia microbiology, Humans, Microbiological Techniques, Microscopy, Transplantation, Homologous adverse effects, Trichosporonosis microbiology, White People, Fungemia diagnosis, Fungemia pathology, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma complications, Trichosporon isolation & purification, Trichosporonosis diagnosis, Trichosporonosis pathology
- Abstract
We report a case of Trichosporon loubieri (T. loubieri) fungemia with likely liver involvement in a 39-year-old Caucasian patient with relapsed B-cell acute lymphoblastic leukemia after an allogeneic hematopoietic cell transplant. This is the fifth published case of T. loubieri infection and only the third case of T. loubieri fungemia, to our knowledge. All 3 cases of T. loubieri infection with fungemia had liver involvement., (© American Society for Clinical Pathology, 2016. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2016
- Full Text
- View/download PDF
50. Systemic Trichosporon loubieri infection in a cat.
- Author
-
Rissi DR, Kirby KD, and Sanchez S
- Subjects
- Animals, Cat Diseases diagnostic imaging, Cats, Diagnosis, Differential, Euthanasia, Animal, Trichosporonosis diagnosis, Cat Diseases diagnosis, Trichosporon isolation & purification, Trichosporonosis veterinary
- Abstract
Our study describes a case of systemic Trichosporon loubieri infection in a cat with acute dyspnea, anorexia, and aggressiveness. Physical examination revealed multiple ulcerative cutaneous lesions on the abdomen, neck, and thorax. Thoracic radiographs and ultrasound showed multiple mediastinal nodules and marked pleural effusion, respectively. A cutaneous biopsy from the ulcerated wounds revealed necrogranulomatous dermatitis and panniculitis with numerous intralesional fungal hyphae. Fungal culture on fresh swab samples from the cutaneous lesions yielded growth of a fungal organism that was further identified as Trichosporon loubieri by PCR and DNA sequencing. The cat was subsequently euthanized and submitted to autopsy. Gross pathology changes consisted of multifocal to coalescing white nodules ranging from 5 to 10 mm in diameter that expanded the mediastinal fat, intrathoracic lymph nodes, lungs, and costal pleura. These lesions consisted of areas of necrogranulomatous inflammation with numerous intralesional fungal hyphae morphologically similar to those observed in the cutaneous biopsy sample. Gross and histologic changes were consistent with a systemic fungal infection, and the etiologic diagnosis was supported by fungal culture. Fungal identity was confirmed by DNA sequencing of D1-D2 and TS1 regions., (© 2016 The Author(s).)
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.